[ad_1]
SYDNEY, December 16, 2025 /PRNewswire/ — Miroma Project Factory (MPF) has delivered a bespoke mobile solution for Screen2Quit, part of the International Lung Study trial and one of Australia’s most ambitious research studies targeting smoking cessation among people undergoing lung cancer screening.
Commissioned by the University of Queensland Thoracic Research Center and developed in partnership with Queensland Health, Screen2Exit is a revised clinical version of My boyfriend who quits Redeveloped and instrumented application to collect back-end participant data for a multi-year randomized controlled trial (RCT). The goal: to determine whether app-based interventions can vastly outperform websites or control conditions in helping people quit smoking, which remains the leading cause of preventable disease worldwide.
From the outside, Screen2Exit This sounds familiar to a smoking cessation app, but beneath the surface lies a purpose-built digital quit engine capable of tracking every interaction, from user-entered quit plans to page scrolling and navigation to community engagement, all while maintaining strict research integrity.
MPF’s mandate included the development of native applications for iOS and Android, as well as the creation of two secure backends. A backend supports community forum moderation, while the bespoke admin portal captures trial-specific analytics and fully anonymized data capture. Each app user is registered via a unique trial ID that controls access and links in-session behavior to anonymized clinical outcomes, allowing researchers to explore the link between digital behaviors and real-world smoking cessation.
“We are proud to contribute to the establishment of a concrete health intervention that is not only scalable, but also scientifically robust,” said Jennifer Wilson, Founder and Futurist MPF. “Screen2Quit takes behavior change out of the lab and into people’s lives, with real-world data to support it. »
The construction was delivered in two structured phases:
- Phase 1 focused on core functionality: integrating updates for trial registration, user navigation improvements, configuring analytics, regional localization, and creating a trial-specific forum with moderation tools.
- Phase 2 added deeper analytics, forum upload capabilities, improved user activity logging, and infrastructure support for multi-jurisdiction deployment.
The app is being deployed as part of the ILST (International Lung Screen Trial), funded by the NHMRC and supported by an interdisciplinary clinical team. MPF continues to support the platform under a multi-year maintenance agreement, providing technical oversight, app store management and hosting infrastructure for the duration of the trial.
About Screen2Quit (MQB UniQLD)
Screen2Quit is a clinical trial app developed for the International Lung Screen Trial, a multi-jurisdictional randomized controlled study coordinated by the University of Queensland Thoracic Research Centre. Based on the evidence-based My QuitBuddy app, Screen2Quit has been redeveloped for use in clinical research, enabling detailed tracking of user behavior and its relationship to smoking cessation outcomes. The app is only available to registered trial participants.
About Miroma Project Factory (MPF)
MPF is a multi-award winning digital product and strategy studio delivering innovative digital solutions across apps, web, platforms and systems. Specializing in purpose-driven technologies, MPF works at the intersection of strategy, design and engineering to create impactful digital products for organizations ready to lead. With deep healthcare expertise, MPF helps clients scale responsibly, communicate clearly, and build meaningful connections with their audiences. For more information, visit www.theprojectfactory.com.
For media inquiries, interviews or partnership opportunities, please contact:
Miroma Project Factory
info@theprojectfactory.com
Henry Marshall
University of Queensland Thoracic Research Center
quit.research@health.qld.gov.au
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/miroma-project-factory-powers-clinical-grade-app-for-one-of-australias-largest-smoking-cessation-trials-302582966.html
SOURCE Miroma Project Factory
[ad_2]
Source: PR Newswire
